Register entry
Duchesnay Inc.
- Registered sites
- 1
- Drug products
- 3
- Live patents
- 5
- Countries
- 1
- Base
- Canada
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
LabellingFinished drug manufacturePackaging
Sites
Facilities
1| Site | Location | Operations | FEI |
|---|---|---|---|
| Duchesnay Inc. | BlainvilleCanada | Labelling, Finished drug manufacture, Packaging | 3009166000 |
Exclusivity
Patents
5Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| BONJESTA | DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE | Feb 2033 |
| OSPHENA | OSPEMIFENE | Jul 2028 |
Catalogue
Marketed products
3Showing 3 of 3.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| BONJESTA | doxylamine succinate and pyridoxine hydrochloride | TABLET, EXTENDED RELEASE | NDA |
| DICLEGIS | doxylamine succinate and pyridoxine hydrochloride | TABLET, DELAYED RELEASE | NDA |
| Osphena | Ospemifene | TABLET, FILM COATED | NDA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.